Back to APGE

Remedium Capital Partners, LLC → APGE

Remedium Capital Partners, LLC APGE Position History

Apogee Therapeutics Inc • Healthcare

Quarters held
4
Latest value
$77.9M
Q2 2026
Peak value
$77.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$44M
Q1 2026$49.1M
Q1 2026$49.1M
Q2 2026$77.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$77.9M586.7K——
Q1 2026$49.1M583.6K——
Q1 2026$49.1M583.6K——
Q4 2025$44M583.6K——

Other funds holding APGE

Other Remedium Capital Partners, LLC positions

ORKA

Oruka Therapeutics Inc

$149M
SYRE

Spyre Therapeutics Inc

$130M
SYRE

Spyre Therapeutics Inc

$103.3M
SYRE

Spyre Therapeutics Inc

$96.2M
ORKA

Oruka Therapeutics Inc

$92.7M
ORKA

Oruka Therapeutics Inc

$79.5M
ORKA

Oruka Therapeutics Inc

$76.8M
SYRE

Spyre Therapeutics Inc

$73.5M